Antibiotic-resistant bacteria are a serious public health threat. Understanding the biology of these bacteria—such as how ...

On National Vaccination Day 2025, let's talk about why vaccines aren’t just for kids! From flu shots to HPV and shingles vaccines, adults need protection too. Staying up to date with vaccinations can ...

The vaccine protects against the serotypes responsible for the majority of adult invasive pneumococcal disease ...

MSD has received approval from the European Commission (EC) for Capvaxive, a pneumococcal 21-valent conjugate vaccine, to ...

Merck & Co. has won approval from the European Commission of its Capvaxive pneumococcal disease vaccine for adults. The Rahway, N.J., drugmaker on Wednesday said the approval covers the 21-valent ...

Babies treated with antibiotics in the first few weeks of their life are likely to show weaker immune responses to essential vaccines taken in ...

Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or ...

Merck’s Capvaxive receives European approval for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults: Rahway, New Jersey Friday, March 28, 2025, 09: ...

Immunization programs save millions of lives every year by protecting against preventable diseases. The immune response to ...